YDES // YD Bio Limited

DES <GO> NASDAQ RQD COCKPIT → CIK 0002011674 ↗

Health Care • Medical Specialities

$5.94 ▲ +0.07 (+1.19%)

MKT CAP: $415.8M • VOL: 47.4K

52W L $2 52W H $16

ALTMAN Z

13.44 SAFE

PIOTROSKI

4 / 9

YDES // ROARABLE RATING & 5-PILLAR RQD CONFIDENCE 02:00 EST DETERMINISTIC ENGINE

▲ UPGRADE // D- (RQD 37) -> D (RQD 44) AS OF 2026-11-02

ROARABLE D

RQD CONFIDENCE

44 / 100 +7D

5 X 20-PT QUANT PILLARS

E 0 D 35 C 59 B 70 A 86+

Roarable Sell — Underperform / Distribution Warning

01 MASSIVE / SEC XBRL

Forensic Fundamentals

8 / 20

WARNING

FCF -120% vs NI -120% • ROIC-WACC -28.6% • Z 13.44

02 INSTITUTIONAL TAPE & TREND

Whale & Options Flow

9 / 20

WARNING

52W RANGE 30% • VS 200D +6.7% • RSI 51.7

03 SEC XBRL CAPITAL ALLOCATION

Insider & Capital Conviction

[LOCKED] FLAGGED

UNLOCK BELOW TO REVEAL

04 FRED 90D r-MATRIX

Macro Regime Fit

10 / 20

NEUTRAL

NEUTRAL • r(10Y)=+0.14 (+23bp) • r(OAS)=+0.04

05 10-K REDLINE AUDIT

Forensic 10-K Risk

[LOCKED] FLAGGED

UNLOCK BELOW TO REVEAL

ALERT

Why did YDES's Insider & Capital Conviction & Forensic 10-K Risk sub-score just flash a warning? Enter your email to unlock the full 5-Pillar Rating Breakdown + get instant alerts whenever YDES is Upgraded or Downgraded.

SIG <GO> CROSS-FEED TRIANGULATION // PROPRIETARY ANOMALY ENGINE (1 ACTIVE ON YDES)

STAGE 2 DETERMINISTIC Z-SCORE + STAGE 3 GEEK DESK BRIEF ALL MARKET ANOMALIES <SIG>

▲ BULLISH // MACRO TAILWIND SCORE (96/100)SIFTER 05 // TRUE NET LIQUIDITY BETA

SEVERITY: 94/100 Z-SCORE: +6.10σ

YDES Posts 96/100 Macro Tailwind Score as Net Liquidity Elasticity Hits 6.00x Beta

TRUE NET LIQUIDITY

$5,746B (-0.64% 4W)

NET LIQUIDITY ELASTICITY

6.00x BETA (r=-0.19)

MACRO TAILWIND SCORE

96 / 100

[GEEK DESK FORENSIC NOTE // FRED WALCL - TGA - RRP × 5Y BETA]

FRED Fed Assets (WALCL)US Treasury TGA (WTREGEN) + ON RRPICE BofA High-Yield OAS + 5Y Equity Beta

Quantitative models register an institutional bullish setup with a Macro Tailwind Score of 96 / 100 and a 6.1 zScore across combined FRED, Treasury, and ICE BofA feeds. Although True Net Liquidity contracted -0.64% over four weeks to $5,746B ($5745.73B), Net Liquidity Elasticity remains elevated at 6.00x BETA with a -0.19 Pearson correlation. With HY OAS 4-week delta widening by only 2 bps, the high macro tailwind severity signals an asymmetric systemic transmission anomaly for YDES positioning.

YDES // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +18.33%▲ ASCENDING CHANNEL

2026-11-02O $6.28H $6.28L $5.87C $5.94VOL 96.2K

RES: $9.05SUP: $2.77SMA50: $5.15SMA200: $5.50

YDES // INSTITUTIONAL BULL VS. BEAR FORENSIC DEBATE

UNDERWEIGHT CONVICTION: 33/100

BEAR 0

100 BULL

YD Bio Limited (YDES) exhibits 28.1% gross margins and -20.0% return on invested capital within Health Care (Medical Specialities), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.

▲ INSTITUTIONAL BULL THESIS (LONG)

01. Operating Leverage & Capital Efficiency Moat

Sustained 28.1% gross profitability converts into -60.0% operating margin and -20.0% ROIC, outpacing sector cost of capital.

ROIC: -20.0% // GM: 28.1%

02. Top-Line Expansion & Cash Conversion

YoY revenue trajectory of +16.9% paired with -1.93% free cash flow yield supports self-funded R&D and capital return.

REV YOY: +16.9% // FCF YLD: -1.93%

03. Balance Sheet Solvency & Forensic Quality

Altman Z-Score of 13.44 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.

ALTMAN Z: 13.44 // F-SCORE: 4/9

▼ INSTITUTIONAL BEAR THESIS (SHORT / RISK)

01. Multiple Compression & Duration Sensitivity

Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.

P/E: 24.0x // EV/EBITDA: —

02. Options Skew & Event Volatility Risk

Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $5.94 max pain.

IMPL MOVE: ±5.2% // P/C: 0.85

03. Competitive Margin & CapEx Cycle Pressure

Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend -60.0% net margins.

NET MARGIN: -60.0% // D/E: 0.45x

KEY CATALYST // Upcoming 10-Q/10-K XBRL margin progression, guidance revision vs — forward consensus, and institutional 13F positioning.

MACRO REGIME // Monitor US 10Y Real Yields (DFII10) and High-Yield Credit Spreads (OAS) for beta-adjusted multiple impact (Beta 1.10).

FORM 4 & 13F FLOW OPEN OWN <GO>

FILER	SIDE	$ VALUE
INSPECT FULL OWNERSHIP LEDGER IN OWN <GO>

UNUSUAL OPTIONS TAPE OPEN OPT <GO>

STRIKE / EXP	TYPE	PREMIUM
INSPECT GEX & CHAIN IN OPT <GO>

KEY VALUATION & PROFITABILITY RATIOS XBRL FA <GO>

TRAILING P/E —

FORWARD P/E —

EV / EBITDA —

FCF YIELD -1.93%

GROSS MARGIN 28.1%

OPERATING MARGIN -60.0%

NET MARGIN -60.0%

ROIC % -20.0%

REV GROWTH YOY +16.9%

DILUTED EPS TTM —

DEBT / EQUITY —

DIVIDEND YIELD 0.00%

RSI-14 MOMENTUM 51.7

5Y EQUITY BETA —

FRED MACRO SENSITIVITY (PEARSON r) ECST <GO>

MACRO CORRELATION CALIBRATION ACTIVE BELOW.

FRED MACRO REGIME STRESS-TEST SIMULATOR // YDESPEARSON R VARIANCE ENGINE

01 // SELECT FEDERAL RESERVE & CREDIT SHOCK SCENARIO

02 // POSITION NOTIONAL EXPOSURE

HEADLINE STRESS SCORE

75/100SEVERE DRAWDOWN PRESSURE

PRIMARY FACTOR EXPOSURE

DFII10 // -0.61 r

Latest: 2.08%

EST. DIRECTIONAL MOVE

-8.50%

Implied Px: $5.44

EST. DOLLAR VARIANCE

-$4,248

On $50,000 Notional

[LOCKED // MULTI-FACTOR DRAWDOWN HEDGE & MACRO TRIGGER ALERT]

Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for YDES & activate live FRED threshold breach alerts.

HEAD-TO-HEAD PEER COMPARISONS COMP <GO>

YDES VS LLY

MARGINS ROIC VALUATION

YDES VS JNJ

MARGINS ROIC VALUATION

YDES VS ABBV

MARGINS ROIC VALUATION

YDES VS UNH

MARGINS ROIC VALUATION